Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies (2019)
- Authors:
- Autor USP: CASTRO JUNIOR, GILBERTO DE - FM
- Unidade: FM
- DOI: 10.1016/j.lungcan.2019.07.004
- Subjects: NEOPLASIAS PULMONARES; CARCINOMA BRONCOGÊNICO; IMUNOTERAPIA; ANTICORPOS MONOCLONAIS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Lung cancer
- ISSN: 0169-5002
- Volume/Número/Paginação/Ano: v. 135, p. 188-195, 2019
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
NOSAKI, Kaname et al. Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies. Lung cancer, v. 135, p. 188-195, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.lungcan.2019.07.004. Acesso em: 14 abr. 2026. -
APA
Nosaki, K., Saka, H., Hosomi, Y., Baas, P., Castro Junior, G. de C., Reck, M., et al. (2019). Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies. Lung cancer, 135, 188-195. doi:10.1016/j.lungcan.2019.07.004 -
NLM
Nosaki K, Saka H, Hosomi Y, Baas P, Castro Junior G de C, Reck M, Wu Y-L, Brahmer JR, Felip E, Sawada T. Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies [Internet]. Lung cancer. 2019 ; 135 188-195.[citado 2026 abr. 14 ] Available from: https://doi.org/10.1016/j.lungcan.2019.07.004 -
Vancouver
Nosaki K, Saka H, Hosomi Y, Baas P, Castro Junior G de C, Reck M, Wu Y-L, Brahmer JR, Felip E, Sawada T. Safety and efficacy of pembrolizumab monotherapy in elderly patients with PD-L1 positive advanced non small-cell lung cancer: Pooled analysis from the KEYNOTE-010, KEYNOTE-024, and KEYNOTE-042 studies [Internet]. Lung cancer. 2019 ; 135 188-195.[citado 2026 abr. 14 ] Available from: https://doi.org/10.1016/j.lungcan.2019.07.004 - Non-gastrointestinal stromal tumours soft tissue sarcomas: an update
- Extraoral photobiomodulation for prevention of oral and oropharyngeal mucositis in head and neck cancer patients: interim analysis of a randomized, double-blind, clinical trial
- Epidemiologia do câncer de pulmão
- Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival: an updated analysis of KEYNOTE-010 trial
- Young head and neck cancer patients are at increased risk of developing oral mucositis and trismus
- The role of single-nucleotide polymorphism (SNPs) in toxicity of induction chemotherapy based on cisplatin and paclitaxel in patients with advanced head and neck cancer
- Desenvolvimento de fármacos: pesquisa clínica e medicina de precisão
- Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
- Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: health-related quality-of-life results from KEYNOTE-048
- Real-World molecular testing and treatment patterns in brazilian patients with newly diagnosed locally advanced or metastatic NSCLC
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
